Acura Pharmaceuticals, Inc. (ACUR.W)

ACUR.W on CBOE When Trading NASDAQ Global Select Market

4.65USD
8 Feb 2010
Price Change (% chg)

$-0.36 (-7.41%)
Prev Close
$4.65
Open
--
Day's High
$4.87
Day's Low
$4.50
Volume
11,156
Avg. Vol
17,501
52-wk High
$9.00
52-wk Low
$4.00

ACUR.W

Chart for ACUR.W

About

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of product candidates providing abuse deterrent features and benefits utilizing its Aversion Technology. The Company’s Aversion Technology platform has been successfully utilized in developing multiple opioid... (more)
No analyst recommendations are available for ACUR.W.

Overall

Beta: 0.34
Market Cap (Mil.): $195.94
Shares Outstanding (Mil.): 42.97
Annual Dividend: 0.00
Yield (%): NA

Financials

  ACUR.W Industry Sector
P/E (TTM): -- 1.96 3.76
EPS (TTM): -157.70 -- --
ROI: -41.48 0.92 2.30
ROE: -41.97 1.27 2.82
view overview for:

King Pharma in pact with Acura to develop painkillers

Oct 31 (Reuters) - King Pharmaceuticals Inc said it has entered into an agreement with Acura Pharmaceuticals Inc to develop painkillers using Acura's Aversion technology.

31 Oct 2007

  Earnings  vs    Estimates

view overview for: